Novel ω-conotoxins from C. catus reverse signs of mouse inflammatory pain after systemic administration

BackgroundAntagonists of N-type voltage-gated calcium channels (VGCC), Cav2.2, can manage severe chronic pain with intrathecal use and may be effective systemically. A series of novel ω-conotoxins that selectively inhibit N-type VGCCs was isolated from Conus catus. In the present study, the potency and reversibility of ω-conotoxins CVID, CVIE and CVIF to inhibit N-type calcium currents were investigated in mouse isolated dorsal root ganglion (DRG) neurons. The systemic potency of each ω-conotoxin to reverse signs of mouse chronic inflammatory pain was also compared.ResultsIn DRG neurons, the rank order of potency to inhibit N-type calcium currents was CVIE > CVIF > CVID. After subcutaneous administration, CVID and CVIE, but not CVIF, partially reversed impaired weight bearing in mice injected with Freund’s complete adjuvant (CFA) three days prior to testing. No side-effects associated with systemic administration of ω-conotoxins were observed.ConclusionsThe present study indicates a potential for CVID and CVIE to be developed as systemically active analgesics with no accompanying neurological side-effects.

• Publication year

  2013

• Venue

  Molecular Pain

• Publication date

  2013-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/1744-8069-9-51PMID 24139484PMCID 3853768
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Pain

  2017cited by this paper
• Spinal actions of ω‐conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model

  2013cited by this paper
• Conus Venom Peptide Pharmacology

  2012influential reference
• Opioid‐related (ORL1) receptors are enriched in a subpopulation of sensory neurons and prolonged activation produces no functional loss of surface N‐type calcium channels

  2012cited by this paper
• Analgesic omega-Conotoxins CVIE and CVIF Selectively and Voltage-Dependently Block Recombinant and Native N-Type Calcium Channels (vol 77, pg 139, 2010)

  2011influential reference
• Analgesic ω-Conotoxins CVIE and CVIF Selectively and Voltage-Dependently Block Recombinant and Native N-Type Calcium Channels

  2010influential reference
• CNSB004 (Leconotide) causes antihyperalgesia without side effects when given intravenously: a comparison with ziconotide in a rat model of diabetic neuropathic pain.

  2010influential reference
• Effects of neuropathy on high-voltage-activated Ca(2+) current in sensory neurones.

  2009cited by this paper
• Ziconotide: an update and review

  2008cited by this paper
• omega-Conotoxin inhibition of excitatory synaptic transmission evoked by dorsal root stimulation in rat superficial dorsal horn.

  2008cited by this paper
• ω‐Conotoxin CVIB differentially inhibits native and recombinant N‐ and P/Q‐type calcium channels

  2007cited by this paper
• Omega-conotoxin CVIB differentially inhibits native and recombinant N- and P/Q-type calcium channels.

  2007cited by this paper
• N-type calcium channel blockers: novel therapeutics for the treatment of pain.

  2006cited by this paper
• A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain.

  2006cited by this paper
• Targeting chronic and neuropathic pain: The N-type calcium channel comes of age

  2005cited by this paper
• Ziconotide, an Intrathecally Administered N‐Type Calcium Channel Antagonist for the Treatment of Chronic Pain

  2005cited by this paper
• Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.

  2004cited by this paper
• The α2δ Auxiliary Subunit Reduces Affinity of ω-Conotoxins for Recombinant N-type (Cav2.2) Calcium Channels*

  2004cited by this paper
• CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain

  2002cited by this paper
• The novel N‐type calcium channel blocker, AM336, produces potent dose‐dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices

  2002cited by this paper
• Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat.

  2002influential reference
• Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse

  2001cited by this paper
• Novel ω-Conotoxins from Conus catus Discriminate among Neuronal Calcium Channel Subtypes*

  2000cited by this paper
• α1E Subunits Form the Pore of Three Cerebellar R-Type Calcium Channels with Different Pharmacological and Permeation Properties

  2000cited by this paper
• ω‐Conotoxin GVIA, the N‐Type Calcium Channel Inhibitor, is Sympatholytic but not Vagolytic: Consequences for Hemodynamics and Autonomic Reflexes in Conscious Rabbits

  1990cited by this paper

• Marine-derived bioactive compounds for neuropathic pain: pharmacology and therapeutic potential

  2025cites this paper
• Pharmacological Classes of Conus Peptides Targeted to Calcium, Sodium, and Potassium Channels.

  2023cites this paper
• Subcutaneous ω-Conotoxins Alleviate Mechanical Pain in Rodent Models of Acute Peripheral Neuropathy

  2021cites this paper
• Structure, function and regulation of CaV 2.2 N-type calcium channels.

  2019cites this paper
• Potential Uses of Isolated Toxin Peptides in Neuropathic Pain Relief: A Literature Review.

  2018cites this paper
• Nicotinic acetylcholine receptors in neuropathic and inflammatory pain

  2018cites this paper
• Block of voltage-gated calcium channels by peptide toxins.

  2017cites this paper
• High-voltage-activated calcium current subtypes in mouse DRG neurons adapt in a subpopulation-specific manner after nerve injury.

  2015cites this paper
• The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential

  2015cites this paper
• Effects of arginine 10 to lysine substitution on ω‐conotoxin CVIE and CVIF block of Cav2.2 channels

  2014cites this paper
• RESEARCH PAPER Effects of arginine 10 to lysine substitution on ω -conotoxin CVIE and CVIF block of Ca v 2.2 channels

  2014cites this paper